Abstract
Objective: This study aimed to evaluate the in vitro efficacy of silver nanoparticles (AgNPs) synthesized by bioreduction using lemongrass (Cymbopogon citratus) essential oil against multidrug-resistant (MDR) bacteria isolated from an Intensive Care Unit (ICU). Methods: The essential oil was extracted and characterized by gas chromatography–mass spectrometry (GC-MS). Antioxidant activity was assessed using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay, the 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assay, and total phenolic content. AgNPs (3 mM and 6 mM silver nitrate) were characterized by UV-Vis spectroscopy, dynamic light scattering (DLS), zeta potential, transmission electron microscopy (TEM), and Fourier-transform infrared (FTIR) spectroscopy. Bacterial isolates were obtained from ICU surfaces and personal protective equipment (PPE). Results: The essential oil presented citral A, citral B, and β-myrcene as major components (97.5% of identified compounds). AgNPs at 3 mM showed smaller size (87 nm), lower Polydispersity Index (0.14), and higher colloidal stability (−23 mV). The 6 mM formulation (147 nm; PDI 0.91; −10 mV) was more effective against a strain of Enterococcus spp. resistant to all antibiotics tested. FTIR analysis indicated the presence of O–H, C=O, and C–O groups involved in nanoparticle stabilization. Discussion: The higher antimicrobial efficacy of the 6 mM formulation was attributed to the greater availability of active AgNPs. Conclusions: The green synthesis of AgNPs using C. citratus essential oil proved effective against MDR bacteria and represents a sustainable and promising alternative for microbiological control in healthcare environments.
Funding Information
  • Fundação de Amparo à Pesquisa e Inovação do Estado Santa Catarina (FAPESC) (FAPESC 12/2020 TO2021TR1482, FAPESC 12/2020 TO2021TR001430, FAPESC 15/2021 TO2021TR001220, FAPESC 54/2022 TO2023TR000648, FAPESC 54/2022 TO2023TR000883, FAPESC 54/2022 TO2023TR000884, FAPESC 15/2023 TO2023TR001418, FAPESC 15/2023 TO2023TR001518, FAPESC n◦ 18/2024, FAPESC n◦ 20/2024, FAPESC n◦ 61/2024, CP FAPESC nº 21/2024, CP FAPESC nº 20/2024, FAPESC Process 863 735/2024, 69/2022-PIBPG)
  • FAPESC 862 (FAPESC 12/2020 TO2021TR1482, FAPESC 12/2020 TO2021TR001430, FAPESC 15/2021 TO2021TR001220, FAPESC 54/2022 TO2023TR000648, FAPESC 54/2022 TO2023TR000883, FAPESC 54/2022 TO2023TR000884, FAPESC 15/2023 TO2023TR001418, FAPESC 15/2023 TO2023TR001518, FAPESC n◦ 18/2024, FAPESC n◦ 20/2024, FAPESC n◦ 61/2024, CP FAPESC nº 21/2024, CP FAPESC nº 20/2024, FAPESC Process 863 735/2024, 69/2022-PIBPG)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (FAPESC 12/2020 TO2021TR1482, FAPESC 12/2020 TO2021TR001430, FAPESC 15/2021 TO2021TR001220, FAPESC 54/2022 TO2023TR000648, FAPESC 54/2022 TO2023TR000883, FAPESC 54/2022 TO2023TR000884, FAPESC 15/2023 TO2023TR001418, FAPESC 15/2023 TO2023TR001518, FAPESC n◦ 18/2024, FAPESC n◦ 20/2024, FAPESC n◦ 61/2024, CP FAPESC nº 21/2024, CP FAPESC nº 20/2024, FAPESC Process 863 735/2024, 69/2022-PIBPG)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)—Programa de Desenvolvimento da Pós-Graduação (PDPG) (FAPESC 12/2020 TO2021TR1482, FAPESC 12/2020 TO2021TR001430, FAPESC 15/2021 TO2021TR001220, FAPESC 54/2022 TO2023TR000648, FAPESC 54/2022 TO2023TR000883, FAPESC 54/2022 TO2023TR000884, FAPESC 15/2023 TO2023TR001418, FAPESC 15/2023 TO2023TR001518, FAPESC n◦ 18/2024, FAPESC n◦ 20/2024, FAPESC n◦ 61/2024, CP FAPESC nº 21/2024, CP FAPESC nº 20/2024, FAPESC Process 863 735/2024, 69/2022-PIBPG)

This publication has 54 references indexed in Scilit: